Advertisement

Care Management for Youth With Comorbid Developmental and Mental Health Conditions: A Discrete Choice Experiment Pilot Study

      Abstract

      Objective

      Caregivers of a child with a coexisting cognitive/intellectual and an emotional/behavior/developmental disability have difficult decisions regarding care management options for their child. This study aimed to pilot and refine an instrument to elicit caregivers’ preferences in managing their child's care needs.

      Methods

      Subjects were 38 caregivers of a child aged 21 and younger with a coexisting cognitive/intellectual and an emotional/behavior/developmental disability. A mixed-methods design was used to develop and pilot a discrete choice experiment (DCE) to elicit care management preferences for their child. Six attributes of care management decisions were tested in the DCE: medication use, parental custody, time cost, social interactions, medication effects, and school placement. Subjects completed a paper-and-pencil survey after which a debriefing discussion was held to obtain feedback that would aid in refining the attribute descriptions. Conditional logistic regression generated mean scores for each attribute. Comments from the debriefing sessions were audio-recorded and used to modify the attribute descriptions.

      Results

      The majority (84%) of subjects were aged 40 years or older and a female caregiver. Common diagnoses of the children were autism spectrum disorder (55%) and attention-deficit/hyperactivity disorder (76%). Subjects preferred using fewer medications and maintaining decision-making authority as opposed to delegating authority to a third party. Medication effects on the child's mood were more important than effects on personality or body weight.

      Conclusions

      The DCE was sensitive to caregivers’ preferences for managing their child's coexisting cognitive/intellectual and emotional/behavior/developmental disability. Findings may help providers gauge treatment in a broader context of health outcomes.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Academic Pediatrics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Boyle CA
        • Boulet S
        • Schieve LA
        • et al.
        Trends in the prevalence of developmental disabilities in US children, 1997–2008.
        Pediatrics. 2011; 127: 1034-1042
        • Antonacci DJ
        • Manuel C
        • Davis E
        Diagnosis and treatment of aggression in individuals with developmental disabilities.
        Psychiatr Q. 2008; 79: 225-247
        • National Alliance for Caregiving
        Caregivers of Children: A Focused Look at Those Caring for a Child With Special Needs Under the Age of 18.
        National Alliance for Caregiving, Bethesda, MD2009
        • Oliver C
        • Petty J
        • Ruddick L
        • et al.
        The association between repetitive, self-injurious and aggressive behavior in children with severe intellectual disability.
        J Autism Dev Disord. 2012; 42: 910-919
        • Ashcroft R
        • Fraser B
        • Kerr M
        • et al.
        Are antipsychotic drugs the right treatment for challenging behaviour in learning disability? The place of a randomised trial.
        J Med Ethics. 2001; 27: 338-343
        • Ageranioti-Belanger S
        • Brunet S
        • D'Anjou G
        • et al.
        Behaviour disorders in children with an intellectual disability.
        Paediatr Child Health. 2012; 17: 84-88
        • Liptak GS
        • Stuart T
        • Auinger P
        Health care utilization and expenditures for children with autism: data from U.S. national samples.
        J Autism Devl Disord. 2006; 36: 871-879
        • Doyle CA
        • McDougle CJ
        Pharmacologic treatments for the behavioral symptoms associated with autism spectrum disorders across the lifespan.
        Dialogues Clin Neurosci. 2012; 14: 263-279
        • Pathak P
        • West D
        • Martin BC
        • et al.
        Evidence-based use of second-generation antipsychotics in a state Medicaid pediatric population, 2001–2005.
        Psychiatr Serv. 2010; 61: 123-129
        • Correll CU
        • Manu P
        • Olshanskiy V
        • et al.
        Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents.
        JAMA. 2009; 302: 1765-1773
        • Andrade SE
        • Lo JC
        • Roblin D
        • et al.
        Antipsychotic medication use among children and risk of diabetes mellitus.
        Pediatrics. 2011; 128: 1135-1141
        • Geller B
        • Luby JL
        • Joshi P
        • et al.
        A randomized controlled trial of risperidone, lithium, or divalproex sodium for initial treatment of bipolar I disorder, manic or mixed phase, in children and adolescents.
        Arch Gen Psychiatry. 2012; 69: 515-528
        • Luby J
        • Mrakotsky C
        • Stalets MM
        • et al.
        Risperidone in preschool children with autistic spectrum disorders: an investigation of safety and efficacy.
        J Child Adolesc Psychopharmacol. 2006; 16: 575-587
        • Dorph-Petersen KA
        • Pierri JN
        • Perel JM
        • et al.
        The influence of chronic exposure to antipsychotic medications on brain size before and after tissue fixation: a comparison of haloperidol and olanzapine in macaque monkeys.
        Neuropsychopharmacology. 2005; 30: 1649-1661
        • Frost DO
        • Page SC
        • Carroll C
        • et al.
        Early exposure to haloperidol or olanzapine induces long-term alterations of dendritic form.
        Synapse. 2010; 64: 191-199
        • Wright ER
        • Kooreman HE
        • Anderson JA
        Service utilization, expenditures, and success in a well-established system of care for young people with serious emotional disorders.
        J Behav Health Serv Res. 2014; 41: 488-502
        • dosReis S
        • Park A
        • Ng X
        • et al.
        Caregiver treatment preferences for children with a new versus existing attention-deficit/hyperactivity disorder diagnosis.
        J Child Adolesc Psychopharmacol. 2017; 27: 234-242
        • dosReis S
        • Castillo WC
        • Ross M
        • et al.
        Attribute development using continuous stakeholder engagement to prioritize treatment decisions: a framework for patient-centered research.
        Value Health. 2016; 19: 758-766
        • Mohamed AF
        • Gonzalez JM
        • Fairchild A
        Patient benefit-risk tradeoffs for radioactive iodine-refractory differentiated thyroid cancer treatments.
        J Thyroid Res. 2015; 2015438235
        • Ryan M
        • Gerard k
        Using discrete choice experiments to value health care programmes: current practice and future research reflections.
        Appl Health Econ Health Policy. 2003; 2: 55-64
        • Ryan M
        • Farrar S
        Using conjoint analysis to elicit preferences for health care.
        BMJ. 2000; 320: 1530-1533
        • Collins D
        Pretesting survey instruments: an overview of cognitive methods.
        Qual Life Res. 2003; 12: 229-238
        • Martin E
        Vignettes and Respondent Debriefing for Questionnaire Design and Evaluation.
        John Wiley & Sons, Inc, Hoboken, NJ2004
        • McFadden D
        Conditional logit analysis of qualitative choice behavior.
        in: Zarembka P Frontiers in Econometrics. Academic Press, New York1974: 105-142
        • McFadden D
        The choice theory approach to market research.
        Marketing Sci. 1986; 5: 275-297
        • Coast J
        • Al-Janabi H
        • Sutton EJ
        • et al.
        Using qualitative methods for attribute development for discrete choice experiments: issues and recommendations.
        Health Econ. 2012; 21: 730-741
        • Coast J
        • Horrocks S
        Developing attributes and levels for discrete choice experiments using qualitative methods.
        J Health Serv Res Policy. 2007; 12: 25-30
        • US Government Accountability Office
        Child Welfare and Juvenile Justice: Federal Agencies Could Play a Stronger Role in Helping States Reduce the Number of Children Placed Solely to Obtain Mental Health Services.
        US Government Accountability Office, Washington, DC2003
        • Cunningham C
        • Deal K
        • Rimas H
        • et al.
        Modeling the information preferences of parents and children with mental health problems: a discrete choice conjoint experiment.
        J Abnorm Child Psychol. 2008; 36: 1123-1138
        • Cunningham CE
        • Deal K
        • Rimas H
        • et al.
        Providing information to parents of children with mental health problems: a discrete choice conjoint analysis of professional preferences.
        J Abnorm Child Psychol. 2009; 37: 1089-1102
        • Schatz NK
        • Fabiano GA
        • Cunningham CE
        • et al.
        Systematic review of patients' and parents' preferences for ADHD treatment options and processes of care.
        Patient. 2015; 8: 483-497
        • dosReis S
        • Ng X
        • Frosch E
        • et al.
        Using best-worst scaling to measure caregiver preferences for managing their child's ADHD: a pilot study.
        Patient. 2014; 8: 423-431
        • Ng X
        • Bridges JF
        • Ross MM
        • et al.
        A latent class analysis to identify variation in caregivers' preferences for their child's attention-deficit/hyperactivity disorder treatment: do stated preferences match current treatment?.
        Patient. 2017; 10: 251-262
        • Castillo WC
        • Ross M
        • Tariq S
        • et al.
        Best-worst scaling to prioritize outcomes meaningful to caregivers of youth with mental health multimorbidities: a pilot study.
        J Dev Behav Pediatr. 2018; 39: 101-108
        • Anixt JS
        • Meinzen-Derr J
        • Estridge H
        • et al.
        Characteristics of treatment decisions to address challenging behaviors in children with autism spectrum disorder.
        J Dev Behav Pediatr. 2018; 39: 282-291